Browsing by Author Nadeu, Ferran

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
5-Jul-2019A practical guide for mutational signature analysis in hematological malignanciesMaura, Francesco; Degasperi, Andrea; Nadeu, Ferran; Leongamornlert, Daniel; Davies, Helen; Moore, Luiza; Royo, Romina; Ziccheddu, Bachisio; Puente, Xose S.; Avet-Loiseau, Hervé; Campbell, Peter J.; Nik-Zainal, Serena; Campo Güerri, Elias; Munshi, Nikhil; Bolli, Niccolò
1-Jan-2019Burkitt-like lymphoma with 11q aberration: A germinal center derived lymphoma genetically unrelated to Burkitt lymphomaGonzález Farré, Blanca; Ramis Zaldivar, Joan Enric; Salmerón Villalobos, Julia; Balagué Ponz, Olga; Celis, Verónica; Verdú Amorós, Jaime; Nadeu, Ferran; Sábado, Constantino; Ferrández, Antonio; Garrido, Marta; García Bragado, Federico; Maya, María Dolores de la; Vagace, José Manuel; Panizo, Carlos Manuel; Astigarraga, Itziar; Andrés, Mara; Jaffe, Elaine S.; Campo Güerri, Elias; Salaverria Frigola, Itziar
1-Jan-2019Cryptic Insertions Of The Immunoglobulin Light Chain Enhancer Region Near CCND1 In T(11;14)-Negative Mantle Cell LymphomaFuster, Carla; Martín García, David; Balagué, Olga; Navarro, Alba; Nadeu, Ferran; Costa, Dolors; Prieto, Miriam; Salaverria Frigola, Itziar; Espinet, Blanca; Rivas Delgado, Alfredo; Terol, Maria José; Giné, Eva; Forcada, Pilar; Ashton-Key, Margaret; Puente, Xose S.; Swerdlow, Steven H.; Beà Bobet, Sílvia M.; Campo Güerri, Elias
23-Sep-2020Genomic determinants of chronic lymphocytic leukemia progression: from individual drivers to a heterogeneous genetic makeupNadeu, Ferran
14-Jan-2022Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II TrialGiné, Eva; Cruz, Fátima de la; Jiménez Ubieto, Ana; López Jimenez, Javier; Martín García-Sancho, Alejandro; Terol, M. José; González Barca, Eva; Casanova, María; Fuente, Adolfo de la; Marín Niebla, Ana; Muntañola, Ana; González López, Tomás José; Aymerich, Marta; Setoain, Xavier; Cortés Romera, Montserrat; Rotger, Amanda; Rodríguez, Sonia; Medina Herrera, Alejandro; García Sanz, Ramón; Nadeu, Ferran; Beà, Silvia; Campo, Elías; López Guillermo, Armando; The GELTAMO Group
Mar-2019Mutations in RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemiaGiménez Carabaza, Neus; Martínez Trillos, Alejandra; Montraveta, Arnau; López-Guerra, Mónica; Rosich, Laia; Nadeu, Ferran; Valero, Juan G.; Aymerich Gregorio, Marta; Magnano, Laura; Rozman, María; Matutes, Estella; Delgado, Julio (Delgado González); Baumann, Tycho; Gine, Eva; González, Marcos; Alcoceba, Miguel; Terol, Maria José; Navarro, Blanca; Colado, Enrique; Payer, Ángel R.; Puente, Xose S.; López-Otin, Carlos; López Guillermo, Armando; Campo Güerri, Elias; Colomer Pujol, Dolors; Villamor i Casas, Neus
5-Mar-2020Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience.Mozas, Pablo; Nadeu, Ferran; Rivas Delgado, Alfredo; Rivero, Andrea; Garrote, Marta; Balagué Ponz, Olga; González Farré, Blanca; Veloza, Luis; Baumann, Tycho; Giné Soca, Eva; Delgado, Julio (Delgado González); Villamor i Casas, Neus; Campo Güerri, Elias; Magnano, Laura; López Guillermo, Armando
21-Apr-2020Timing the initiation of multiple myeloma.Rustad, Even H.; Yellapantula, Venkata; Leongamornlert, Daniel; Bolli, Niccolò; Ledergor, Guy; Nadeu, Ferran; Angelopoulos, Nicos; Dawson, Kevin J.; Mitchell, Thomas J.; Osborne, Robert J.; Ziccheddu, Bachisio; Carniti, Cristiana; Montefusco, Vittorio; Corradini, Paolo; Anderson, Kenneth C.; Moreau, Philippe; Papaemmanuil, Elli; Alexandrov, Ludmil B.; Puente, Xose S.; Campo Güerri, Elias; Siebert, Reiner; Avet Loiseau, Herve; Landgren, Ola; Munshi, Nikhil; Campbell, Peter J.; Maura, Francesco